Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02486757 · ClinicalTrials.gov registry record · Early Phase 1
Investigation of Female Reproductive Hormone Dynamics During Adolescence
A Early Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT02486757: Completed Early Phase 1 study, sponsored by Massachusetts General Hospital.
NCT02486757 is a Early Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02486757, a Early Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Irregular menstrual cycles are common in girls for several years after their first menstrual period. The cause of abnormal menstrual cycles during this time is not well-understood. The purpose of this study is to: 1) monitor girls during a menstrual cycle (with blood and urine sampling and serial pelvic ultrasounds) to identify those girls who do not ovulate (release of an egg from the ovary), and 2) determine whether cycles can be corrected by treating girls with a short course of low-dose estrogen and progesterone.
Interventions
- DRUG transdermal estradiol
- DRUG micronized progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-03-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02486757
The ClinicalTrials.gov registry entry for NCT02486757 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transdermal estradiol is the first listed.
NCT02486757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02486757 about?
NCT02486757 is a clinical study titled "Investigation of Female Reproductive Hormone Dynamics During Adolescence". Irregular menstrual cycles are common in girls for several years after their first menstrual period. The cause of abnormal menstrual cycles during this time is not well-understood. The purpose of this study is to: 1) monitor girls during a menstrual cycle (with blood and urine sampling and serial pe...
What is the current status of trial NCT02486757?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2015-04. Estimated completion is 2016-03-01.
What interventions are being tested in trial NCT02486757?
The interventions under investigation include: transdermal estradiol (DRUG), micronized progesterone (DRUG).
Who is sponsoring clinical trial NCT02486757?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.